Brambilla M, Barbetta F, Nardo G, Agnelli L, et al. Refining High-Risk EGFR-Mutant Lung Cancer Patients: The Role of Adjusted Variant Allele Frequency in First-Line Osimertinib Therapy. Clin Lung Cancer 2025 Aug 31:S1525-7304(25)00221.
PMID: 40976722